Authors:
Cryan, JF
Dalvi, A
Jin, SH
Hirsch, BR
Lucki, I
Thomas, SA
Citation: Jf. Cryan et al., Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs, J PHARM EXP, 298(2), 2001, pp. 651-657
Citation: Jf. Cryan et Be. Leonard, 5-HT1A and beyond: The role of serotonin and its receptors in depression and the antidepressant response, HUM PSYCHOP, 15(2), 2000, pp. 113-135
Citation: Jf. Cryan et I. Lucki, Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine(2C)receptors, J PHARM EXP, 295(3), 2000, pp. 1120-1126
Citation: Jf. Cryan et I. Lucki, 5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test, EUR J PHARM, 409(3), 2000, pp. 295-299
Authors:
Cryan, JF
Harkin, A
Naughton, M
Kelly, JP
Leonard, BE
Citation: Jf. Cryan et al., Characterization of D-fenfluramine-induced hypothermia: evidence for multiple sites of action, EUR J PHARM, 390(3), 2000, pp. 275-285
Authors:
Cryan, JF
Kelliher, P
Kelly, JP
Leonard, BE
Citation: Jf. Cryan et al., Comparative effects of serotonergic agonists with varying efficacy at the 5-HT1A receptor on core body temperature: modification by the selective 5-HT1A receptor antagonist WAY 100635, J PSYCHOPH, 13(3), 1999, pp. 278-283
Authors:
Cryan, JF
McGrath, C
Leonard, BE
Norman, TR
Citation: Jf. Cryan et al., Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat, PHARM BIO B, 63(2), 1999, pp. 333-338